Apollo Hospitals Enterprise Limited — Updates, 12-08-2025: Press Release

Apollo Hospitals posted robust quarterly results, with consolidated revenue up 15% YoY to Rs. 5,842 Cr and PAT surging 42% YoY to Rs. 433 Cr. A key strategic move includes acquiring the remaining 50% stake in Apollo Gleneagles PET-CT for Rs. 8.5 Cr, making it a wholly-owned diagnostic subsidiary. The demerger of the omnichannel pharmacy and digital health business into Apollo Healthtech Ltd is progressing, aiming to unlock shareholder value. Significant expansion plans target adding 4,370 new beds over the next 3-4 years. New AI-powered initiatives like Apollo Zen and Oralife were also launched for advanced preventive care.